Triangle Pharmaceuticals
🏢 View company profile →8Patents
0Active
8Granted
26Portfolio score
Filing activity: Apr 7, 1998 → Mar 29, 2002
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6081786A | Systems, methods and computer program products for guiding the selection of therapeutic treatment regimens | Emerging Cross-Sectional Technologies | 218 | Expired |
| US6188988A | Systems, methods and computer program products for guiding the selection of therapeutic treatment regimens | Emerging Cross-Sectional Technologies | 151 | Expired |
| US6215004A | Method of manufacture of 1,3-oxathiolane nucleosides | Chemistry; Metallurgy | 6 | Expired |
| US6518425B1 | Method of manufacture of 1,3-oxathiolane nucleosides | Chemistry; Metallurgy | 2 | Expired |
| US6410546B1 | Use of MKC-442 in combination with other antiviral agents | Human Necessities | 1 | Expired |
| US6870048B2 | Process for the preparation of 2'-halo-β-L-arabinofuranosyl nucleosides | Chemistry; Metallurgy | 1 | Expired |
| US6528515B1 | Combination therapy to treat hepatitis B virus | Human Necessities | 0 | Expired |
| US6576776B1 | Method of manufacture of 1,3-oxathiolane nucleosides | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.